<DOC>
	<DOCNO>NCT00556777</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . Giving intraoperative radiation therapy may reduce amount normal tissue need remove . PURPOSE : This phase II trial study well give radiation therapy surgery work treat old woman stage I breast cancer .</brief_summary>
	<brief_title>Radiation Therapy During Surgery Treating Older Women With Stage I Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Study feasibility reproducibility intraoperative radiotherapy treatment lumpectomy old woman stage I breast cancer . Secondary - Study impact regimen maintain self-care . - Study quality life ( QLQ-C30 ) satisfaction care . - Study regimen tolerance cosmetic result . - Evaluate economic impact treatment . - Study relapse-free disease-specific survival . OUTLINE : Patients undergo conservative breast surgery axillary node dissection ( sentinel node classic resection ) . At point , patient must either negative axillary lymph node removal ≥ 6 lymph node , negative sentinel node , limited lumpectomy negative margin ≥ 2 mm . Patients undergo intraoperative radiotherapy surgery , close reconstruction breast . Patients may begin hormonal therapy complete study therapy . After completion study therapy , patient follow every 3 month 1 year , every 4 month 1 year , every 6 month 3 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Inclusion criterion : Histologically confirm stage I breast cancer Size ≤ 20 mm ( ultrasound ) , N0 , quadrant Hormone receptor status specify Exclusion criterion : Distant metastasis Inflammatory breast cancer Lobular situ disease Invasive cancer ductal carcinoma situ Nonepithelial disease sarcoma Multicentric disease Lymphatic embolism Margins safety unknown positive ( situ invasive ) Preoperative mammography show diffuse microcalcification PATIENT CHARACTERISTICS : Female Menopausal Karnofsky 70100 % No prior cancer except basal cell skin cancer , uterine epithelioma situ , cancer complete remission past 5 year No geographic , social , psychiatric reason would impede participation study treatment PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior neoadjuvant therapy No concurrent participation another study</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>stage I breast cancer</keyword>
</DOC>